What Does 99% Semaglutide Purity Mean? HPLC, Mass Spectrometry & COA Explained

A 99% semaglutide purity result usually refers to chromatographic purity measured by HPLC. It does not mean that 99% of the total vial mass is semaglutide. HPLC purity, molecular identity, and net peptide content describe different analytical characteristics, so each result should be interpreted separately.

For example, the current Profound Peptides Semaglutide RUO batch reports 99.712% purity and 12.86 mg confirmed net peptide content. The batch was tested using HPLC with UV detection and mass spectrometry. These numbers describe different properties of the same tested sample.

Understanding that distinction makes it easier to evaluate a semaglutide certificate of analysis, or COA, and determine what the reported laboratory results actually show.

What Does 99% Semaglutide Purity Actually Mean?

When a laboratory reports semaglutide at 99% purity by HPLC, the percentage generally represents the relative chromatographic area attributed to the main semaglutide peak compared with other detected peaks under the test conditions.

HPLC separates components within a prepared sample. A detector records those components as peaks on a chromatogram. When supported by the analytical method and identity data, the dominant peak represents the target compound. Smaller peaks may represent detectable impurities, degradation products, or other components.

A reported value of 99% therefore describes the sample’s chromatographic profile. It should not be interpreted as a direct measurement showing that 99% of everything physically present in a vial, by weight, is semaglutide.

Key distinction: HPLC purity describes relative chromatographic purity. Net peptide content describes the measured quantity of peptide in the tested sample.

This distinction is important because purity and quantity may both appear on the same COA while answering separate analytical questions.

How Is Semaglutide Purity Measured Using HPLC?

High-performance liquid chromatography, or HPLC, separates compounds according to how they interact with the chromatographic system.

A prepared sample enters a column with a flowing mobile phase. Different components move through the column at different rates. When they reach the detector, the system records their responses and produces a chromatogram.

What Does an HPLC Chromatogram Show?

An HPLC chromatogram provides a visual record of detected components. Common features include:

• Retention time: when a component reaches the detector
• Main peak: the dominant chromatographic signal
• Minor peaks: additional detected components
• Peak area: the integrated detector response for a peak
• Area percentage: a peak’s relative contribution to the measured chromatographic area

A dominant main peak with limited secondary peak area can support a high chromatographic purity result.

The reported value still depends on the analytical method, detector, sample preparation, chromatographic conditions, and data integration. This is why the percentage should always be read together with information about how the analysis was performed.

What HPLC Cannot Tell You on Its Own

HPLC is useful for separation and purity assessment, but chromatographic behavior alone does not provide complete molecular identification.

A retention time or dominant peak can support identification when compared with an appropriate method or reference, but additional analytical techniques can provide stronger molecular evidence.

This is where mass spectrometry becomes useful.

What Does Mass Spectrometry Tell Researchers About Semaglutide?

Mass spectrometry analyzes ions according to their mass-to-charge ratio. The resulting data can show whether the measured molecular species is consistent with the expected compound.

HPLC and mass spectrometry therefore provide complementary information.

Analytical Element	What It Helps Assess
HPLC	Chromatographic purity and separation
Chromatogram	Main peak, minor peaks, and relative peak areas
Mass spectrometry	Molecular mass and identity support
Net peptide content	Measured peptide quantity
Lot number	Batch traceability
COA	Analytical results and sample documentation

FDA quality-review documentation for approved pharmaceutical semaglutide describes characterization using multiple analytical techniques, including mass spectrometry and HPLC methods. Published semaglutide research has also combined liquid chromatography with high-resolution mass spectrometry to separate and characterize peptide-related impurities.

These references illustrate how complementary analytical methods are used in peptide characterization. They do not evaluate, approve, or endorse the research-use-only batch discussed in this article.

Semaglutide Purity vs Net Peptide Content

A purity percentage and a peptide-content result should not be treated as the same measurement.

Consider the current Profound Peptides batch:

• HPLC purity: 99.712%
• Confirmed net peptide content: 12.86 mg

The 99.712% figure describes chromatographic purity. The 12.86 mg figure describes the quantity of peptide reported for the tested sample.

This also explains why a nominal vial specification and laboratory-measured peptide content can show different values. A nominal vial size is a product specification. Net peptide content is an analytical measurement associated with the tested sample.

Research on peptide reference standards published by scientists from the United States Pharmacopeial Convention also treats identity, purity, impurities, and quantitative content as distinct analytical considerations. A complete assessment may therefore require several complementary measurements rather than a single headline percentage.

What Is a Semaglutide Certificate of Analysis?

A semaglutide certificate of analysis summarizes reported laboratory information for a specific sample or batch.

The exact format varies by laboratory and by the scope of testing, but a useful COA may include:

• Compound or sample identification
• Lot or batch number
• Testing and reporting dates
• HPLC purity result
• Analytical method information
• Mass spectrometry data
• Net peptide content when measured
• Testing laboratory
• Accession number, search code, or report identifier

A COA should be read within its stated scope. Laboratory results apply to the submitted sample. They do not automatically establish every characteristic of every vial or a different production batch.

The lot number is particularly important because it helps connect published analytical results to the batch being evaluated.

How to Read a Semaglutide COA

Start with the compound name and lot number. Make sure the report corresponds to the material being reviewed.

Next, examine the purity result and analytical method. If the report lists HPLC purity, check whether it identifies the detector or provides a chromatogram.

Then review any mass spectrometry data. Molecular-mass information can provide identity support that complements the chromatographic result.

Check peptide content separately from purity. A value expressed in milligrams answers a different question from an HPLC area percentage.

Finally, look for report verification information. An accession number, laboratory search code, or other report identifier allows the published data to be connected with the underlying laboratory documentation.

A COA becomes more useful when the compound, batch, analytical methods, and verification information can all be traced clearly.

Example: Interpreting a 99.712% Semaglutide Purity Result

At the time this article was reviewed, the current Semaglutide RUO 10mg product page lists the following batch-specific information:

Parameter	Reported Result
Purity	99.712%
Net peptide content	12.86 mg
Testing method	HPLC with UV Detection + Mass Spectrometry
Lot number	SM10-2252026
COA accession	2603130113
Search code	Prof2603130113
Testing laboratory	Freedom Diagnostics

The value of this dataset comes from the relationship between the results, not simply the 99.712% figure.

HPLC provides the reported chromatographic purity. Mass spectrometry provides identity-related molecular information. The separate peptide-content result reports quantity. The lot number connects those results with a specific batch, while the accession number and search code provide a path for verifying the laboratory report.

Researchers reviewing the Semaglutide RUO 10mg specifications can therefore evaluate the purity result alongside the measured peptide content, testing method, and batch documentation rather than relying on one percentage alone.

Why Batch-Specific Semaglutide Testing Matters

Analytical results relate to the sample tested by the laboratory. A result from one lot should not automatically be assumed to represent another batch.

Matching the COA lot number with the current product listing improves traceability. If the lot changes, the analytical documentation associated with the new batch should also be reviewed.

This is why a current COA can provide more useful information than an undated purity statement. The current Semaglutide batch specifications identify the lot, analytical method, reported purity, measured content, and report-verification details in one place.

Batch traceability does not replace analytical testing. It connects the reported test results to the material those results are intended to represent.

Frequently Asked Questions About Semaglutide Purity and COAs